by Sergio A. Giralt, MD; John Koreth, MBBS, DPhil; and Robert S. Negrin, MD
The goals of allogeneic hematopoietic stem cell transplantation (allo-HSCT) are multifaceted and include maintaining the graft-versus-tumor (GVT) e......READ MORE
by Sergio A. Giralt, MD; John Koreth, MBBS, DPhil; and Robert S. Negrin, MD
Fibrosis and sclerosis are central to the pathogenesis of chronic graft-versus-host disease (cGVHD) and its most severe manifestations. Monitoring ......READ MORE
by Corey Cutler, MD, MPH, FRCPC; David Miklos, MD, PhD; and Edmund K. Waller, MD, PhD, FACP
As the underlying pathways involved in chronic graft-versus-host disease (cGVHD) are becoming better understood, novel therapies targeting these pa......READ MORE
by Corey Cutler, MD, MPH, FRCPC; David Miklos, MD, PhD; and Edmund K. Waller, MD, PhD, FACP
The treatment of chronic graft-versus-host disease (cGVHD) now includes novel systemic therapies in addition to established agents such as corticos......READ MORE
by Daniel R. Couriel, MD, MS; Corey Cutler, MD, MPH, FRCP(C); and Sergio A. Giralt, MD
A major recent development in chronic graft-versus-host disease (cGVHD) has been the emergence of novel treatments that more precisely target the d......READ MORE
